Jiujiang No.1 People's Hospital
11
5
6
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
27%
3 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Hemorrhage Stroke Decision Making Model Based Deep Learning (BrainHemoAI System)
Role: collaborator
Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)
Role: collaborator
Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion
Role: collaborator
Tirofiban After Successful MT Recanalization in AIS
Role: collaborator
Multimodal Neurofunctional Profiling in Stroke
Role: collaborator
Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period
Role: collaborator
Effect of Premedication With Pronase on Mucosal Cleanliness During EGD
Role: collaborator
Gegen Qinlian Tang and Probiotics for Radiation Enteritis
Role: lead
Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases
Role: collaborator
Stroke Registration of Young Adults in China
Role: collaborator
Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia
Role: lead
All 11 trials loaded